Ardelyx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. 

CEO
Michael G. Raab
CEOMichael G. Raab
Employees
489
Employees489
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
489
Employees489

ARDX Key Statistics

Market cap
1.51B
Market cap1.51B
Price-Earnings ratio
-25.65
Price-Earnings ratio-25.65
Dividend yield
Dividend yield
Average volume
3.20M
Average volume3.20M
High today
$6.41
High today$6.41
Low today
$6.08
Low today$6.08
Open price
$6.35
Open price$6.35
Volume
2.32M
Volume2.32M
52 Week high
$8.40
52 Week high$8.40
52 Week low
$3.49
52 Week low$3.49

Stock Snapshot

With a market cap of 1.51B, Ardelyx(ARDX) trades at $6.20. The stock has a price-to-earnings ratio of -25.65.

During the trading session on 2026-05-25, Ardelyx(ARDX) shares reached a daily high of $6.41 and a low of $6.08. At a current price of $6.20, the stock is +2.0% higher than the low and still -3.3% under the high.

Trading volume for Ardelyx(ARDX) stock has reached 2.32M, versus its average volume of 3.2M.

The stock's 52-week range extends from a low of $3.49 to a high of $8.40.

The stock's 52-week range extends from a low of $3.49 to a high of $8.40.

ARDX News

Investing.com 3d
Ardelyx chief patient officer sells $43,803 in shares - Investing.com

...

Ardelyx chief patient officer sells $43,803 in shares - Investing.com
TipRanks 6d
Ardelyx Earnings Call Highlights Rapid Growth, Rising Costs

Ardelyx Inc ((ARDX)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerfu...

Simply Wall St 6d
A Look At Ardelyx Valuation After New Long Term XPHOZAH Data Strengthens Safety And Efficacy Profile

Ardelyx (ARDX) is back in focus after presenting long term data on its phosphate absorption inhibitor XPHOZAH at the National Kidney Foundation’s Spring Clinica...

A Look At Ardelyx Valuation After New Long Term XPHOZAH Data Strengthens Safety And Efficacy Profile

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.